Literature DB >> 12562591

Parahippocampal volume deficits in subjects with aging-associated cognitive decline.

Johannes Pantel1, Benita Kratz, Marco Essig, Johannes Schröder.   

Abstract

OBJECTIVE: Neuropathological evidence suggests that the earliest changes in Alzheimer's disease selectively affect the parahippocampal regions of the brain. This study was conducted to determine if otherwise healthy elderly subjects with mild cognitive impairment had structural volume deficits affecting the parahippocampal gyrus.
METHOD: Magnetic resonance imaging (MRI) was used to compare global and regional brain volumes in 21 subjects with mild cognitive deficits defined according to the criteria for aging-associated cognitive decline, 22 cognitively intact comparison subjects, and 12 patients with Alzheimer's disease.
RESULTS: Compared with the cognitively intact subjects, the subjects with aging-associated cognitive decline had a significantly smaller mean volume of the right parahippocampal gyrus. The subjects with aging-associated cognitive decline had a mean parahippocampal volume that was intermediate between that of the Alzheimer's disease patients and that of the cognitively intact subjects.
CONCLUSIONS: Parahippocampal atrophy underlies the observed cognitive deficits in aging-associated cognitive decline. These findings support the hypothesis that aging-associated cognitive decline represents a preclinical stage of Alzheimer's disease.

Entities:  

Mesh:

Year:  2003        PMID: 12562591     DOI: 10.1176/appi.ajp.160.2.379

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  [Functional magnetic resonance imaging and dementia].

Authors:  F L Giesel; A Hempel; P Schönknecht; T Wüstenberg; M A Weber; J Schröder; M Essig
Journal:  Radiologe       Date:  2003-06-24       Impact factor: 0.635

2.  [MR spectroscopy in dementia].

Authors:  T Hauser; L Gerigk; F Giesel; L Schuster; M Essig
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

3.  MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Authors:  D P Devanand; Ravi Bansal; Jun Liu; Xuejun Hao; Gnanavalli Pradhaban; Bradley S Peterson
Journal:  Neuroimage       Date:  2012-01-25       Impact factor: 6.556

4.  [Mild cognitive impairment: diagnostic value of different MR techniques].

Authors:  T Hauser; P A Thomann; B Stieltjes; M Essig
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

Review 5.  Structural imaging in early pre-states of dementia.

Authors:  Charles D Smith
Journal:  Biochim Biophys Acta       Date:  2011-07-14

6.  Gray Matter Volume Covariance Networks, Social Support, and Cognition in Older Adults.

Authors:  Kelly Cotton; Joe Verghese; Helena M Blumen
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2020-06-02       Impact factor: 4.077

7.  Extracting patterns of morphometry distinguishing HIV associated neurodegeneration from mild cognitive impairment via group cardinality constrained classification.

Authors:  Yong Zhang; Dongjin Kwon; Pardis Esmaeili-Firidouni; Adolf Pfefferbaum; Edith V Sullivan; Harold Javitz; Victor Valcour; Kilian M Pohl
Journal:  Hum Brain Mapp       Date:  2016-08-04       Impact factor: 5.038

8.  Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment.

Authors:  F L Giesel; H K Hahn; P A Thomann; E Widjaja; E Wignall; H von Tengg-Kobligk; J Pantel; P D Griffiths; H O Peitgen; J Schroder; M Essig
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

9.  [Symptoms and imaging diagnostics of neurodegenerative dementia].

Authors:  P Schönknecht; C Sattler; P Toro; M Essig
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

10.  Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease.

Authors:  Philipp A Thomann; Elmar Kaiser; Peter Schönknecht; Johannes Pantel; Marco Essig; Johannes Schröder
Journal:  J Psychiatry Neurosci       Date:  2009-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.